Choksi Laboratories share news, announcements and annual reports
BSE: 526546Healthcare ServicesSmall Cap
Choksi Laboratories Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1994
Last close ₹195.30down ₹9.50 (4.64%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹204.80.
30 Oct: open ₹204.80, high ₹209.00, low ₹194.60
52-week range of traded prices to 30 Oct 2026
₹81.85Low, 4 Mar 2026₹227.90High, 28 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹136 Cr3,091st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 62.93
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹0.78 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 98.31
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.32
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹0.78 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 5.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 9.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.18
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,834
Choksi Laboratories board meetings
114 filed, newest first. Page 2 of 3.
Jun 2021
25 Jun · Board meeting
Meeting on 30 Jun 2021: audited results and quarterly results
Feb 2021
3 Feb · Board meeting
Meeting on 10 Feb 2021: quarterly results
Nov 2020
3 Nov · Board meeting
Meeting on 11 Nov 2020: quarterly results
Aug 2020
29 Aug · Board meeting
26 Aug · Board meeting
Meeting on 29 Aug 2020: quarterly results and annual general meeting24 Aug · Board meeting
Jul 2020
27 Jul · Board meeting
Meeting on 30 Jul 2020: quarterly results
Feb 2020
14 Feb · Board meeting
4 Feb · Board meeting
Meeting on 14 Feb 2020: quarterly results
Nov 2019
6 Nov · Board meeting
Meeting on 14 Nov 2019: quarterly results
Aug 2019
1 Aug · Board meeting
Meeting on 12 Aug 2019: quarterly results
May 2019
30 May · Board meeting
20 May · Board meeting
Meeting on 30 May 2019: audited results
Feb 2019
4 Feb · Board meeting
Meeting on 13 Feb 2019: quarterly results
Nov 2018
Aug 2018
13 Aug · Board meeting
May 2018
30 May · Board meeting
Mar 2018
Feb 2018
Nov 2017
Aug 2017
May 2017
12 May · Board meeting
Mar 2017
Feb 2017
Sep 2016
Aug 2016
May 2016
28 May · Board meeting
Board of Directors of the Company at its meeting held on May 28, 2016, inter alia, has transacted the following: 1. Taken on record ....
Mar 2016
25 Mar · Board meeting
With reference to the earlier announcement dated March 21, 2016, regarding Outcome of Board Meeting. Choksi Laboratories Ltd has now informed BSE that the following business were transacted ....21 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 21, 2016, has transacted the following; 1. Ms. Himika Choksi has ....